BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 27
• 30
• 31

• BioForest

  H. Lundbeck A/S Release: SABRIL® (vigabatrin) Vision Data Presented In Two Late-Breaking Posters At American Society of Hematology Annual Meeting

  December 9, 2013

   · 

  1 min read
• Drug Development

  ImmunoGen, Inc. Announces Favorable Initial Safety And Response Findings For CD38-Targeting Anticancer Compound, SAR650984

  December 9, 2013

   · 

  1 min read
• TherapeuticsMD, Inc. Receives Notice Of Allowance For Patent Covering Platform Technology Of Oral Combination Bioidentical 17ß-Estradiol And Progesterone

  December 9, 2013

   · 

  1 min read
• Genetown

  AesRx Presents Phase 1/2a Trial Data Of Anti-Sickling Agent Aes-103 At American Society of Hematology

  December 9, 2013

   · 

  5 min read
• BioForest

  Cell Therapeutics, Inc. Release: Integrated Safety And Efficacy Analysis Of Phase 2 Clinical Trials Of Pacritinib In Patients With Myelofibrosis And Low Platelet Counts Presented At American Society of Hematology Annual Meeting

  December 9, 2013

   · 

  8 min read
• Drug Development

  Infinity Pharmaceuticals Inc. Reports Updated Phase 1 Data Showing Encouraging Clinical Activity Of IPI-145 In Chronic Lymphocytic Leukemia And T-Cell Lymphoma At American Society of Hematology Annual Meeting

  December 9, 2013

   · 

  1 min read
• Cytoo’s 2D+/3D Cell Culture Platform In The Spotlight With Manuel Thery Presenting At The ASCB 2013 Annual Meeting

  December 9, 2013

   · 

  2 min read
• Business

  Nuevolution Appoints Ton Berkien As Chief Business Officer

  December 9, 2013

   · 

  4 min read
• Drug Development

  Nimbus Discovery IRAK4 Inhibitor Demonstrates Synergistic Effects In Preclinical Studies With Three Kinase Inhibitors For The Treatment Of Lymphoid Malignancies

  December 9, 2013

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc. Announces Interim Phase 2 Results For GS-9973 In Previously Treated Chronic Lymphocytic Leukemia

  December 9, 2013

   · 

  1 min read